Breast cancer cells start off growing in the breast and end up spreading to the lung, liver, bones and brain. This spreading to another organ is called metastasis and is the major cause of patient death due to breast cancer. Although many scientists generally understand how the tumor starts growing in the breast, they do not exactly understand how the cells are able to establish themselves in the lung, liver, bones and brain. This manuscript looks at two different cell lines, 67NR cells that have a low level of metastasis, or spreading to another organ, and 4T1 cells that easily metastasize. The 4T1 and 67NR breast cancer cell lines are established cell lines that were previously isolated from the breast tumors of mice and are the basis of our experiments. We injected these cells into mice, allowed the cells to grow into tumors, and then removed the tumors to see the differences between them. We found that 4T1 cells were able to metastasize to the lungs, liver, heart, kidney, spleen, bone and brain. When we injected the 67NR cells, they still formed tumors, but the cells were only able to metastasize to the lung. We isolated these tumors and discovered that 4T1 are more aggressive because they have decreased expression of an important protein called TNF-α.

TNF-α was first discovered in the blood of mice injected with a tuberculosis injection. Many people debate whether TNF-α promotes cancer cell growth or prevents it but our studies show that it prevents metastasis. We even went on to add pure TNF-α to the cells and saw that 67NR cells were more sensitive to it. This means that the entire pathway is shut down in 4T1 cells. This has great therapeutic importance because physicians can treat non-metastatic cells with TNF-α to kill them but they know they need another drug to kill highly metastatic cells. Studies like this are important because we have discovered that the shutdown of the TNF-α pathway is one of the reasons why 4T1 cells metastasize.

Mazvita Maziveyi, Suresh Alahari
Department of Biochemistry and Molecular Biology, LSUHSC School of Medicine,
New Orleans, USA

Publication

Altered Tumor Necrosis factor-Alpha signaling pathway between high and low metastatic carcinoma clones derived from single tumor
Maziveyi M, Subramaniam V, Dash SK and Alahari SK
Journal of Comprehensive Cancer Research. 2017

Read offline:     

Related Articles:

	Autophagy suppression decreases craniofacial bone mass Macroautophagy (hereafter autophagy) is the main intracellular degradation mechanism to maintain cellular homeostasis by degrading misfolded proteins, recycling dysfunctional organelles, and generating energy fuels under physiological and pathological conditions. Autophagy…
	Exercise inhibits cancer: the mechanosensitive state… Surprisingly, researchers find that tumor cells are sensitive to mechanical stresses. This may provide new ways to treat cancers without the severe side-effects of many therapies. Because mechanosensitivity of cancer…
	Arming macrophages to stop cancer progression Macrophages are a type of immune cells that fight infection and support tissue remodeling. They are best known as phagocytes which engulf bacteria and damaged cells stimulating other immune cells.…
	Defects in mismatch repair increase cancer risk and… Microsatellites are formed by 1-6 nucleotide base pairs that are repeated in direct order 5-50 times. Repetitive DNA including microsatellites are mainly present in non-coding DNA regions that occupy more…
	How PET ameliorates 90-Yttrium therapy in inoperable… Increased synthesis of blood vessels and blood supply are essential characteristics of a tumor to secure nutrient delivery and growth. One of the treatment options for inoperable liver cancer (hepatocellular carcinoma,…
	Purification and characterization of a… Alzheimer’s Disease (AD) is an incurable disease that causes memory, reasoning and thinking to deteriorate over time. AD is marked by brain atrophy and plaque-like deposits of a small peptide…